Muhammad Kashif

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Newly Diagnosed

Multiple Myeloma

Peritoneal Dialysis

Top Venues

American journal of hematology

European journal of haematology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Hareth Nahi, Gabriel Afram, Katarina Uttervall, Sandra Lockmer, Love Tätting, Gösta Gahrton, Muhammad Kashif, Evren Alici, Olga Stromberg, Monika Klimkowska, Johan Lund
Minimal residual disease status is the prognostic determinant following high-dose treatment for patients with multiple myeloma. Cancer medicine (2023)
Garbriel Afram, Roza Chaireti, Katarina Uttervall, Vincent Luong, Johan Lund, Muhammad Kashif, Gösta Gahrton, Evren Alici, Hareth Nahi
Conditioning with melphalan 200 mg/m 2 and subsequent ASCT improves progression-free and overall survival in elderly myeloma patients compared to standard of care. European journal of haematology 109 (6) (2022)
Sandra Lockmer, Katarina Uttervall, Muhammad Kashif, Carina Svärd, Katarina Malmsten, Evellyn Fletcher-Torres, Evren Alici, Johan Lund, Hareth Nahi
Antibody response to COVID-19 mRNA vaccine (Comirnaty) in myeloma patients treated with high-dose melphalan and/or immunotherapy. American journal of hematology 96 (11) (2021)
Hareth Nahi, Muhammad Kashif, Monika Klimkowska, Maria Karvouni, Ann Wallblom, Charlotte Gran, Julia Hauenstein, Nicolai Frengen, Charlotte Gustafsson, Gabriel Afram, Katarina Uttervall, Johan Lund, Robert Månsson, Arnika K Wagner, Evren Alici
Low dose venetoclax as a single agent treatment of plasma cell malignancies harboring t(11;14). American journal of hematology 96 (8) (2021)